Kaplan-Meier survival curve revealed that DLBCL patients with positive eIF3a expression displayed shorter OS than those negative, though there was no statistical significance (Fig. 1G, P = 0.096). The gene discussed is EIF3A; the disease is diffuse large B-cell lymphoma.